Nordea Investment Management AB Purchases 9,058 Shares of HealthEquity, Inc. $HQY

Nordea Investment Management AB increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 15.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 68,790 shares of the company’s stock after acquiring an additional 9,058 shares during the quarter. Nordea Investment Management AB owned about 0.08% of HealthEquity worth $6,515,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its position in HealthEquity by 232.4% during the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in shares of HealthEquity during the second quarter worth approximately $33,000. True Wealth Design LLC lifted its holdings in HealthEquity by 3,522.2% in the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after buying an additional 317 shares during the period. Cullen Frost Bankers Inc. lifted its holdings in HealthEquity by 172.3% in the second quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock valued at $37,000 after buying an additional 224 shares during the period. Finally, Sellwood Investment Partners LLC bought a new position in HealthEquity in the second quarter valued at approximately $58,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Price Performance

HQY stock opened at $85.37 on Friday. The stock has a 50-day moving average price of $96.16 and a two-hundred day moving average price of $94.54. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65. The stock has a market cap of $7.29 billion, a PE ratio of 39.16, a price-to-earnings-growth ratio of 1.23 and a beta of 0.20. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million during the quarter, compared to analysts’ expectations of $320.92 million. During the same period in the prior year, the firm earned $0.78 earnings per share. HealthEquity’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on HQY. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. JMP Securities set a $122.00 target price on HealthEquity in a research report on Thursday, December 4th. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Sunday, January 11th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $130.00 target price on shares of HealthEquity in a research note on Thursday, December 4th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $119.60.

Insiders Place Their Bets

In related news, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. The trade was a 1.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 15,459 shares of company stock worth $1,483,062. 1.50% of the stock is currently owned by insiders.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.